ClinicalTrials.gg
CompletedNCT05520333Updated Jun 8, 2025Results posted

Brief Intervention to Prevent Alcohol Socialization (BIPAS Alcohol)

An interventional study of BIPAS Alcohol in Alcohol Drinking, Adolescent, Drinking Behavior and Drinking, Alcohol, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-08.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Early alcohol socialization occurs within the family. This multi-level, high-reach, low-intensity intervention to prevent early alcohol use capitalizes on the influence of providers, immunization timing, and pediatric guidelines that advise healthcare providers to give anticipatory guidance about early alcohol use. In conjunction, the intervention capitalizes on the power of technology to reinforce and expand upon pediatrician messages.

The study seeks to understand the feasibility and effectiveness of a pilot intervention designed to prevent alcohol socialization through education of parents of rising 6th grade students.

02

Conditions studied

  • Alcohol Drinking, Adolescent
  • Drinking Behavior
  • Drinking, Alcohol
  • Adolescent Behavior
03

In context

Underage Drinking

44 studies on the registry are indexed under Underage Drinking; 13 are open to participants now.

This study's enrollment of 132 is below the median of 360 across 43 interventional studies indexed under Underage Drinking.

Browse Underage Drinking studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,372 studies on the registry; 133 are open to participants now.

Of its 161 completed or terminated interventional studies of FDA-regulated products, 139 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years or older;
  • Parent or guardian of an enrolled child at a study clinic;
  • Cohabitate part time (2 days/week) or more with enrolled child;
  • Be able to complete study activities in English;
  • Be able to give ;
  • Own a phone with text message capabilities and access to internet.

Exclusion criteria

Exclusion Criteria:

  • Families in which the 10-to-12-year old child is actively receiving treatment for alcohol use disorder.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
132 participants (actual)

Study arms

  • Experimental
    Intervention arm

    Families receive text messages for three months.

    Behavioral: BIPAS Alcohol

  • No intervention
    Waitlist-control arm

    Families are randomized into a control group for three months and begin receiving text messages for three months.

Interventions

  • BehavioralBIPAS Alcohol

    Weekly text messages for three months.

06

What researchers measure

Primary outcomes

  1. Change in Mean Value of Parental Pro-sipping Beliefs Score

    Parental Alcohol Socialization Beliefs, Attitudes, and Practices scale (eight items). A four-point scale ranging from "strongly disagree" (lowest value=1) to "strongly agree" (highest value=4) will be used, with higher values on the scale indicating a more pro-sipping belief system. The scores will have a range from 8-32. Higher values are associated with worse outcomes.

    Time frame: Baseline, three months

07

Results

Posted Jun 8, 2025

Participant flow

Recruitment occurred from May to November 2023. Participants were recruited through school newsletters, social media posts, information dissemination through educational institutions and local pediatric clinics, and word of mouth.

Participant flow — Overall Study
MilestoneIntervention ArmWaitlist-control Arm
Started6963
Completed6657
Not completed36
Withdrew: Lost to follow-up36

Outcome measures

PrimaryChange in Mean Value of Parental Pro-sipping Beliefs Score

Parental Alcohol Socialization Beliefs, Attitudes, and Practices scale (eight items). A four-point scale ranging from "strongly disagree" (lowest value=1) to "strongly agree" (highest value=4) will be used, with higher values on the scale indicating a more pro-sipping belief system. The scores will have a range from 8-32. Higher values are associated with worse outcomes.

Time frame:
Baseline, three months
Reported as:
Mean · score on a scale
Change in Mean Value of Parental Pro-sipping Beliefs Score
score on a scaleIntervention ArmWaitlist-control Arm
Change in Mean Value of Parental Pro-sipping Beliefs Score0.13 ± 0.140.08 ± 0.16

Adverse events

Collected over Adverse events were not collected.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention Arm———
Waitlist-control Arm———

Baseline characteristics

Note that demographics were only collected for parent participants (not children).

Age, Categorical
Age, Categorical(Participants)Intervention ArmWaitlist-control ArmTotal
<=18 years000
Between 18 and 65 years6963132
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Intervention ArmWaitlist-control ArmTotal
Female——0
Male——0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Intervention ArmWaitlist-control ArmTotal
Hispanic or Latino336
Not Hispanic or Latino6657123
Unknown or Not Reported033
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Intervention ArmWaitlist-control ArmTotal
American Indian or Alaska Native000
Asian358
Native Hawaiian or Other Pacific Islander000
Black or African American303
White6152113
More than one race123
Unknown or Not Reported145
Parent drinks alcohol
Parent drinks alcohol(Participants)Intervention ArmWaitlist-control ArmTotal
Yes5647103
No131629
Parent/guardian relationship with child
Parent/guardian relationship with child(Participants)Intervention ArmWaitlist-control ArmTotal
Mother6154115
Father8816
Guardian011
08

Study locations

1 site
  • University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — This study will be following NIAAA's requirements regarding sharing outcome data of sharing de-identified, individual-level data to the NIAAA Data Archive. The data are made public after an embargo period following the end date of the research award.

Time frame: after an embargo period following the end date of the research award

Access criteria: In accordance with NIAAA data archive requirements.

Data sharing details ↗ · www.niaaa.nih.gov

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05520333
Responsible party
Sponsor
First posted
Aug 29, 2022
Start date
May 1, 2023
Primary completion
Jul 30, 2024
Completion
Jul 30, 2024
Results posted
Jun 8, 2025
Last update
Jun 8, 2025

Study contacts

Melissa Gilkey, PhD
principal investigator · UNC Chapel Hill

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion